Recently, representatives from the winning 2022-2023 IPhO VIP Case Competition student chapter - University of California, San Francisco (UCSF) - were privileged to attend the annual Bladder Cancer Advocacy Network (BCAN) Think Tank Meeting in Washington, DC, as a result of a collaboration between IPhO, BCAN, Seagen, and Astellas.
For the past three years, IPhO has partnered with organizations that are committed to the professional development and advancement of underrepresented PharmD students.
As part of this important initiative in 2023, scholarships were provided to 38 Black, Hispanic, and Native American student pharmacists, who now have access to a year of IPhO Membership, Annual Meeting Registration, and a suite of Fellowship preparation resources.
Congratulations to this year's scholarship recipients, and thank you to the generous scholarship supporters below:
Dr. Aaron-Albert Hargrove, PharmD Manager - Central Clinical Services Eli Lilly LinkedIn Profile
What was your motivation to pursue the pharmaceutical industry as a career path?
As a student, I worked in retail and hospital pharmacy. I became engrossed in various pharmaceutical journals and medical reviews. The therapeutic indications were fascinating, however, the data never reflected on the everyday population that I continuously served. So, I immediately saw a need and I knew the pharmaceutical industry is where I could make the biggest impact.
Talk about diversity, equity, and inclusion in the pharmaceutical industry; what should companies be doing to continue making progress?
Companies should continue advocating for DEI efforts. They need to realize that this is a movement, not a moment. Pamphlets/brochures with diverse ethnicities aren't enough. They should have diverse leadership on every level of the organization.
Dr. LaToya Benjamin, PharmD Associate Director, Medical Omnichannel & Independent Education Eli Lilly LinkedIn Profile
What was your motivation to pursue the pharmaceutical industry as a career path?
I desired a career that provided space for me to constantly evolve, impact large patient populations and have a healthy work/life balance. Endless opportunities for pharmacists within the pharmaceutical industry were the determining factor. The only limitations are self-imposed.
Talk about diversity, equity, and inclusion in the pharmaceutical industry; what should companies be doing to continue making progress?
Understanding that diversity includes everyone is the major key. Companies should continue to evaluate the reason and need for investment in DEI. Have those tough conversations and be vulnerable from the top down. If the desire to change is genuine to the core, the work that follows will align and eventually lead to the difference respective companies are seeking.
Industry Pharmacists Organization (IPhO) is pleased to announce the release of a new publication: Number of PharmDs Entering Industry Upon Graduation from 2020-2022
In 2022, 748 PharmDs entered the US-based pharmaceutical industry upon graduation. This represents more than 5% of all graduating pharmacists—and the number has been increasing each year!
The 2022-23 student leadership term has been incredibly productive and exciting for our IPhO National Student Officers (NSOs) and Regional Student Officers (RSOs). We want to take a moment to thank them for their numerous accomplishments. These leaders worked tirelessly to ensure that all IPhO student pharmacists were well informed about the resources and tools available to them.
What was your motivation to pursue the pharmaceutical industry as a career path?
My motivation is to help bring new medicines to patients. The pharmaceutical industry provides an ecosystem to learn and discover new things and is dynamic, fast-moving, and at the cutting edge of technology.
Talk about diversity, equity, and inclusion in the pharmaceutical industry; what should companies be doing to continue making progress?
Develop initiatives that will bring new ideas in. Create workforce pipeline programs with colleges and high schools to directly engage equitable and diverse talent. Encourage on-site visits and gap-year alternatives. Recruit and hire regionally and provide opportunities for students to apply for internships or experiential rotations at all times during the year. These initiatives will help the pharmaceutical sector remain competitive and grow stronger.
In a single weekend, IPhO chapters from across the country gathered for three collaborative events:
IPhO Philly Chapter Conference, March 31
IPhO Northeast Regional Meeting (NERM), April 1
IPhO Purdue Chapter Industry Pharmacist Symposium, April 1
Students worked incredibly hard to plan events offering insightful takeaways and networking opportunities for all industry-minded attendees. And we're pleased to report that all three events achieved their goals! Congratulations to everyone involved.
IPhO is pleased to announce the release of two new publications that analyze feedback and opinions of student pharmacists, Fellowship applicants, and incoming Fellows regarding Fellowship recruitment processes and ASHP Midyear attendance.
These reports provide valuable insights not only for students pursuing a Fellowship, but also for Fellowship stakeholders who are planning for the fall 2023 recruitment and application cycle.
The reports below can be accessed and downloaded here (see Scholarly Publications and Posters section):
Class of 2023 Fellowship Applicants: Recruiting and Midyear Findings
Class of 2024: Fellowship Recruiting Process Preferences
Industry Pharmacists Organization (IPhO) is pleased to announce the release of its first Diversity Initiatives Analysis! For the past two years, IPhO and its supporters have launched multiple initiatives aimed at increasing equity and inclusion in the pharmaceutical industry—including skill development opportunities and tailored workshops focusing on virtual interviewing, public speaking, and presenting for industry to help student pharmacists of color advance in their careers.
In addition, IPhO and its partners have awarded scholarships to students of color to enhance equity and access to a variety of valuable IPhO resources, including IPhO Membership, Annual Meeting Registration, and 1-1 Coaching.
The goal of this research was to assess the value of IPhO diversity initiatives and their impact on helping student pharmacists of color succeed in the pursuit of a pharmaceutical industry career.
One important takeaway was that, compared to the 20% national average of obtaining a Fellowship position, 55.6% of the 2022 IPhO Diversity Scholarship Recipients obtained a Fellowship position upon completion of their PharmD curriculum. This is an increase from the 44.4% of IPhO Diversity Scholarship Recipients from 2021.
In September 2022, 72 IPhO student chapters from across the country embarked on a six-month professional journey to create a drug development plan that would bring a theoretical new bladder cancer medicine to market.
This year's winning team did an extraordinary job putting together a comprehensive drug development plan and was especially impressive when justifying their thinking at key decision points throughout the competition. Congratulations to our winning team members for going above and beyond at every stage!
Team representatives will present their case at the annual BCAN Bladder Cancer Think Tank Meeting in Washington, DC this August.
Vivi Le, PharmD Pharmaceutical Marketing Fellow - Copywriter RevHealth
Can you give a brief overview of your fellowship and its structure and value within your company?
Pharmaceutical marketing Fellows at RevHealth have the opportunity to rotate between two main areas: content development and account services. Content development works internally to develop promotional/educational materials, translate scientific data to digestible messages, and help create concepts/campaign ideation for our clients. Account services is the client-facing role in which they work externally with the clients to develop strategic plans, formulate key competitive insights, and oversee development of marketing materials with cross-functional teams through promotional review. The PharmD Fellows at RevHealth are regarded as valuable additions to the team as we have the clinical expertise to ensure all messaging is scientifically sound.
In September 2022, 72 IPhO student chapters from across the country embarked on a six-month professional journey to create a drug development plan that would bring a theoretical new bladder cancer medicine to market.
Congratulations to our second-place winner! Our reviewers were impressed by this team's strong submission, collaboration, and attention to detail. This is a very well-deserved recognition!
In September 2022, 72 IPhO student chapters from across the country embarked on a six-month professional journey to create a drug development plan that would bring a theoretical new bladder cancer medicine to market.
Congratulations to the two teams below for placing in third and fourth in this year's competition. Both submissions were thorough, innovative, and creative. All participants should be incredibly proud of their hard work!
In September 2022, 72 IPhO student chapters from across the country embarked on a six-month professional journey to create a drug development plan that would bring a theoretical new bladder cancer medicine to market.
Participating teams were asked to cover drug development from many perspectives, including clinical development, medical strategy, regulatory affairs, and marketing. With support from the Bladder Cancer Advocacy Network (BCAN) team, students also incorporated patient advocacy best practices into their submissions—ensuring that the patient voice is always kept top-of-mind throughout the drug development lifecycle.
There are 830 PharmDs currently participating in US-based, industry-focused postgraduate Fellowships. This is a 12.5% increase over last year and a record number.
What was your motivation to pursue the pharmaceutical industry as a career path?
I had many motivations to pursue the pharmaceutical industry and particularly regulatory affairs as a career path. When I was completing my APPE rotations as a pharmacy student, I had a rotation with AbbVie pharmaceuticals in regulatory affairs advertising and promotion. I learned so much from that experience and I saw the continuous growth, in knowledge but also in opportunities for career advancement, which I found appealing. I gravitated towards regulatory affairs because this function attaches you to innovation in new therapies, new mechanisms, new technologies, etc. This made sense to me as a career path, as I was always excited to lead/work on new projects throughout pharmacy school.
If you're looking to break into industry as a PharmD, this resource is for you! In addition to fellowships, direct-to-industry roles are a great option for pharmacists to begin their careers. Check out different employment options in the infographic below, as well as our tips for applying.
If you're looking to enter industry without a fellowship, don't miss our newly released direct-to-industry analysis, now available on the IPhO website. From this publication, you'll learn about the roles that were most common for the 253 Class of 2022 graduates who entered industry without a fellowship, along with details about the employers that hired them.
We've shared many times that roughly 80% of pharmacists currently working in industry never completed a fellowship. And we continue to reinforce that statistic because it's important that graduating pharmacy students know that a fellowship is not the only way to launch an industry career!